Literature DB >> 29873125

Willingness to use an in-hospital supervised inhalation room among people who smoke crack cocaine in Vancouver, Canada.

Sandra Cortina1, Mary Clare Kennedy2,3, Huiru Dong2,3, Nadia Fairbairn1,2, Kanna Hayashi2,4, M-J Milloy1,2, Thomas Kerr1,2.   

Abstract

INTRODUCTION AND AIMS: People who use illicit drugs (PWUD) often engage in drug use during hospitalisation. Adverse outcomes may arise from efforts to conceal inpatient drug use, especially in hospital settings that rely on abstinence-based policies. Harm reduction interventions, including supervised drug consumption services, have not been well studied in hospital settings. This study examines factors associated with willingness to use an in-hospital supervised inhalation room (SIR) among people who smoke crack cocaine in Vancouver, Canada. DESIGN AND METHODS: Cross-sectional data from two open prospective cohorts of PWUD involving people who smoke crack cocaine were collected between June 2013 and May 2014. Multivariable logistic regression analyses were used to identify factors associated with willingness to use an in-hospital SIR.
RESULTS: Among 539 participants, 320 (59.4%) reported willingness to use an in-hospital SIR. Independent factors positively associated with willingness included: ever used drugs in hospital [adjusted odds ratio (AOR) = 1.89], and daily non-injection crack use (AOR = 1.63). Difficulty accessing new crack pipes (AOR = 0.51) was negatively associated with willingness (all P < 0.05). The most commonly reported reasons for willingness were to: remain in hospital (50.6%), reduce drug-related risks (25.6%) and reduce the stress of hospital discharge for using drugs (24.7%). DISCUSSION AND
CONCLUSIONS: A high proportion of people who smoke crack cocaine reported willingness to use an in-hospital SIR, and those willing were more likely to report heavy drug use and previous in-hospital use. These findings highlight the potential utility of SIRs to complement existing in-hospital services for PWUD.
© 2018 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  addiction; crack cocaine; hospital utilisation; supervised drug consumption services; supervised inhalation room

Mesh:

Substances:

Year:  2018        PMID: 29873125      PMCID: PMC6094948          DOI: 10.1111/dar.12815

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  29 in total

1.  Commentary on Salmon et al. (2010): The case for safer inhalation facilities--waiting to inhale.

Authors:  Steffanie A Strathdee; Javier Rio Navarro
Journal:  Addiction       Date:  2010-04       Impact factor: 6.526

2.  Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: utility of a mixed methods approach.

Authors:  Loren Brener; William von Hippel; Courtney von Hippel; Ilyse Resnick; Carla Treloar
Journal:  Drug Alcohol Rev       Date:  2010-09

3.  Hospitals as a 'risk environment': an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs.

Authors:  Ryan McNeil; Will Small; Evan Wood; Thomas Kerr
Journal:  Soc Sci Med       Date:  2014-01-19       Impact factor: 4.634

Review 4.  Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review.

Authors:  Leonieke C van Boekel; Evelien P M Brouwers; Jaap van Weeghel; Henk F L Garretsen
Journal:  Drug Alcohol Depend       Date:  2013-03-13       Impact factor: 4.492

5.  Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.

Authors:  Viviane D Lima; Richard Harrigan; Melanie Murray; David M Moore; Evan Wood; Robert S Hogg; Julio Sg Montaner
Journal:  AIDS       Date:  2008-11-12       Impact factor: 4.177

6.  Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population.

Authors:  Marc G Romney; Mark W Hull; Réka Gustafson; Jat Sandhu; Sylvie Champagne; Titus Wong; Anouf Nematallah; Sara Forsting; Patricia Daly
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

7.  Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia.

Authors:  Benedikt Fischer; Jeff Powis; Michelle Firestone Cruz; Katherine Rudzinski; Jürgen Rehm
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-01       Impact factor: 2.566

8.  Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals.

Authors:  Ryan McNeil; Thomas Kerr; Bernie Pauly; Evan Wood; Will Small
Journal:  Addiction       Date:  2016-01-08       Impact factor: 6.526

9.  Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users.

Authors:  Kate Shannon; Tomiye Ishida; Robert Morgan; Arthur Bear; Megan Oleson; Thomas Kerr; Mark W Tyndall
Journal:  Harm Reduct J       Date:  2006-01-10

10.  A cost-benefit/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada.

Authors:  Ehsan Jozaghi
Journal:  Harm Reduct J       Date:  2014-11-13
View more
  3 in total

1.  'Resurgent', 'twin' or 'silent' epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America.

Authors:  Benedikt Fischer; Caroline O'Keefe-Markman; Angelica Min-Hye Lee; Dimitri Daldegan-Bueno
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-02-15

2.  Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs.

Authors:  Geoff Bardwell; Tamar Austin; Lisa Maher; Jade Boyd
Journal:  Harm Reduct J       Date:  2021-03-07

3.  Feasibility, acceptability, concerns, and challenges of implementing supervised injection services at a specialty HIV hospital in Toronto, Canada: perspectives of people living with HIV.

Authors:  Katherine Rudzinski; Jessica Xavier; Adrian Guta; Soo Chan Carusone; Kenneth King; J Craig Phillips; Sarah Switzer; Bill O'Leary; Rosalind Baltzer Turje; Scott Harrison; Karen de Prinse; Joanne Simons; Carol Strike
Journal:  BMC Public Health       Date:  2021-07-29       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.